These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23407483)

  • 1. Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma).
    Bourcier ME; Vinik AI
    Pancreas; 2013 Mar; 42(2):348-52. PubMed ID: 23407483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib achieved fast and sustained control of VIPoma symptoms.
    de Mestier L; Walter T; Brixi H; Lombard-Bohas C; Cadiot G
    Eur J Endocrinol; 2015 Jan; 172(1):K1-3. PubMed ID: 25305306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of sunitinib in patients with advanced neuroendocrine tumors.
    Kulke MH; Lenz HJ; Meropol NJ; Posey J; Ryan DP; Picus J; Bergsland E; Stuart K; Tye L; Huang X; Li JZ; Baum CM; Fuchs CS
    J Clin Oncol; 2008 Jul; 26(20):3403-10. PubMed ID: 18612155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic paraganglioma and treatment with sunitinib: a case report.
    Cirillo F
    Tumori; 2010; 96(6):1022-7. PubMed ID: 21388069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
    Arnaud L; Schartz NE; Bousquet G; Sarandi F; Verola O; Madelaine I; Kerob D; Lebbe C
    J Clin Oncol; 2008 Mar; 26(9):1569-71. PubMed ID: 18349416
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma.
    La Vine DB; Coleman TA; Davis CH; Carbonell CE; Davis WB
    Am J Clin Oncol; 2010 Jun; 33(3):217-20. PubMed ID: 19745694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis.
    Eichelberg C; Heuer R; Chun FK; Hinrichs K; Zacharias M; Huland H; Heinzer H
    Eur Urol; 2008 Dec; 54(6):1373-8. PubMed ID: 18692304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
    Johannsen M; Flörcken A; Bex A; Roigas J; Cosentino M; Ficarra V; Kloeters C; Rief M; Rogalla P; Miller K; Grünwald V
    Eur Urol; 2009 Jun; 55(6):1430-8. PubMed ID: 18950936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
    Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
    Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic hepatic epithelioid hemangio-endothelioma: long-term response to sunitinib malate.
    Saada E; Saint Paul MC; Gugenheim J; Follana P; François E
    Oncol Res Treat; 2014; 37(3):124-6. PubMed ID: 24685916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metastatic Vipoma by liver transplantation.
    Bramley PN; Lodge JP; Losowsky MS; Giles GR
    Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
    Masini C; Sabbatini R; Porta C; Procopio G; Di Lorenzo G; Onofri A; Buti S; Iacovelli R; Invernizzi R; Moscetti L; Aste MG; Pagano M; Grosso F; Lucia Manenti A; Ortega C; Cosmai L; Del Giovane C; Conte PF
    BJU Int; 2012 Sep; 110(5):692-8. PubMed ID: 22364110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma.
    Ayllon J; Beuselinck B; Morel A; Barrascout E; Medioni J; Scotte F; Oudard S
    Cancer Invest; 2011 May; 29(4):282-5. PubMed ID: 21469976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and safety of sunitinib in a heavily pre-treated metastatic non-small cell lung carcinoma patient.
    Tassi R; Muto A; Rangan S; Vannini A; Politi L; Neri B
    Anticancer Res; 2010 Dec; 30(12):5169-73. PubMed ID: 21187507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib in patients with metastatic renal cell carcinoma.
    Motzer RJ; Rini BI; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Merchan JR; Wilding G; Ginsberg MS; Bacik J; Kim ST; Baum CM; Michaelson MD
    JAMA; 2006 Jun; 295(21):2516-24. PubMed ID: 16757724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-up.
    Zhang CJ; Zhao PJ; Li XS; Zhao J; Huang LH; Song Y; Gong K; Shen C; Yu W; Song G; Zhao Z; Zhang Z; Zhang Q; He ZS; Jin J; Zhou LQ
    Chin Med J (Engl); 2013; 126(15):2826-9. PubMed ID: 23924450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic vipoma arising from colonic primary tumour.
    Bradley C; Haddock G; Pickard RG; Rankin EM
    Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.